NuScale Power RoPower Contract Delay to Late 2026 Spurs 15% Stock Surge
NuScale Power's first SMR sale for Romania's RoPower plant has been delayed from early 2026 to late 2026 or early 2027, with financing uncertain. Meanwhile, its reactor design gained NRC approval last summer and shares jumped 15.1% on January 5 as nuclear policy support surged, despite a 9% year-over-year decline.
1. Company Strives for First SMR Sale
NuScale Power generates revenue today through consulting work supporting Fluor’s preparation for RoPower’s final investment decision on a six-unit small modular reactor (SMR) plant in Romania. That contract would mark the company’s first confirmed SMR sale. Initially targeted for approval in early 2026, RoPower’s decision has slipped to late 2026 or early 2027, raising concerns over project financing given the plant’s estimated multi-billion-dollar capital requirement. Until that order is finalized, NuScale’s ability to transition from engineering services into full reactor licensing and construction remains unproven.
2. Partnership Pipeline Remains Uncertain
Beyond RoPower, NuScale has signed framework agreements with the Tennessee Valley Authority and ENTRA1 Energy to explore SMR deployments. While NuScale has outlined technical milestones—such as design certification deliverables and site analysis reports—it has not committed to binding purchase schedules or pricing terms. Without concrete timelines or funding commitments from these utilities, potential reactor sales remain speculative, leaving investors reliant on progress reports rather than firm backlog.
3. Policy Support Spurs Investor Interest
Federal support has accelerated since the Nuclear Regulatory Commission approved NuScale’s latest SMR design last summer. At the start of 2026, the U.S. House Energy Subcommittee scheduled hearings on reducing nuclear licensing lead times and implementing four executive orders that aim to have three experimental reactors online by mid-2026, multiple SMRs by the end of 2027 and a reactor on a military base by 2028. These policy tailwinds have driven trading volumes sharply higher—peaking at nearly 70 million shares on January 5—despite lingering questions over deployment feasibility before 2030.
4. Volatility and Financial Runway
NuScale’s stock has swung as much as +150% and –40% over the past year, and remains approximately 70% below its 52-week high. The company ended Q3 with $750 million in liquidity, providing at least 12–18 months of runway at current burn rates. However, without firm SMR orders or construction contracts, NuScale will continue to rely on equity raises that risk shareholder dilution. Investors must weigh the potential for a million-dollar payoff if SMR commercialization succeeds against the real possibility of prolonged losses if new reactor commitments do not materialize.